G1 Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (3)

Latest Posts

About This Stock More About This Stock
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
4 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Wednesday, January 10, 2018 7:20 PM EDT
The biotech “run-up” trade has always attracted a wide array of traders looking to take advantage of potentially high alpha price moves before the actual catalyst/binary event come to fruition.
In this article: JNCE, MYOK, GTHX, SRRA Also: MRK, RHHBY, VRTX, LLY, XBI
Read
G1 Therapeutics Announces Closing Of Initial Public Offering
Article By: NASDAQ GlobeNewswire
Tuesday, May 23, 2017 10:14 AM EDT
G1 Therapeutics, Inc., today announced the closing of its initial public offering of 7,781,564 shares of common stock at a public offering price of $15.00 per share.
In this article: GTHX
Read

PARTNER HEADLINES

Latest Tweets for $GTHX

No tweets yet!